Logo image of VSEE

VSEE HEALTH INC (VSEE) Stock Fundamental Analysis

NASDAQ:VSEE - Nasdaq - US92919Y1029 - Common Stock - Currency: USD

1.33  -0.03 (-2.21%)

Fundamental Rating

0

We assign a fundamental rating of 0 out of 10 to VSEE. VSEE was compared to 36 industry peers in the Health Care Technology industry. VSEE has a bad profitability rating. Also its financial health evaluation is rather negative. VSEE does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year VSEE has reported negative net income.
VSEE had a negative operating cash flow in the past year.
In the past 5 years VSEE always reported negative net income.
VSEE had a negative operating cash flow in each of the past 5 years.
VSEE Yearly Net Income VS EBIT VS OCF VS FCFVSEE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 -1M -2M -3M

1.2 Ratios

With a Return On Assets value of -219.52%, VSEE is not doing good in the industry: 88.89% of the companies in the same industry are doing better.
With a Return On Equity value of -1154.56%, VSEE is not doing good in the industry: 83.33% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -219.52%
ROE -1154.56%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
VSEE Yearly ROA, ROE, ROICVSEE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 100 -100 -200 -300 -400

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for VSEE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
VSEE Yearly Profit, Operating, Gross MarginsVSEE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 20 -20 40 -40 60

More info and screens

0

2. Health

2.1 Basic Checks

VSEE does not have a ROIC to compare to the WACC, probably because it is not profitable.
VSEE has more shares outstanding than it did 1 year ago.
VSEE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
VSEE Yearly Shares OutstandingVSEE Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 5B 10B 15B
VSEE Yearly Total Debt VS Total AssetsVSEE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

VSEE has an Altman-Z score of -3.47. This is a bad value and indicates that VSEE is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of VSEE (-3.47) is worse than 72.22% of its industry peers.
A Debt/Equity ratio of 1.96 is on the high side and indicates that VSEE has dependencies on debt financing.
The Debt to Equity ratio of VSEE (1.96) is worse than 83.33% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.96
Debt/FCF N/A
Altman-Z -3.47
ROIC/WACCN/A
WACC10.55%
VSEE Yearly LT Debt VS Equity VS FCFVSEE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 20M 40M 60M 80M 100M

2.3 Liquidity

A Current Ratio of 0.37 indicates that VSEE may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.37, VSEE is doing worse than 88.89% of the companies in the same industry.
A Quick Ratio of 0.37 indicates that VSEE may have some problems paying its short term obligations.
VSEE has a worse Quick ratio (0.37) than 88.89% of its industry peers.
Industry RankSector Rank
Current Ratio 0.37
Quick Ratio 0.37
VSEE Yearly Current Assets VS Current LiabilitesVSEE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 1M 2M 3M 4M

More info and screens

2

3. Growth

3.1 Past

The earnings per share for VSEE have decreased strongly by -623.42% in the last year.
The Revenue for VSEE has decreased by -100.00% in the past year. This is quite bad
EPS 1Y (TTM)-623.42%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-18114.44%
Revenue 1Y (TTM)-100%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

VSEE is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -182.84% yearly.
The Revenue is expected to grow by 46.40% on average over the next years. This is a very strong growth
EPS Next Y-1100%
EPS Next 2Y-182.84%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year64.83%
Revenue Next 2Y46.4%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

VSEE Yearly Revenue VS EstimatesVSEE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 5M 10M 15M 20M
VSEE Yearly EPS VS EstimatesVSEE Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 -0.1 -0.2 -0.3

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for VSEE. In the last year negative earnings were reported.
Also next year VSEE is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
VSEE Price Earnings VS Forward Price EarningsVSEE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
VSEE Per share dataVSEE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -1 -2 -3 -4

4.3 Compensation for Growth

A cheap valuation may be justified as VSEE's earnings are expected to decrease with -182.84% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-182.84%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for VSEE!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

VSEE HEALTH INC

NASDAQ:VSEE (7/25/2025, 8:00:01 PM)

1.33

-0.03 (-2.21%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)05-26 2025-05-26
Earnings (Next)07-31 2025-07-31
Inst Owners8.7%
Inst Owner Change-68.77%
Ins Owners40.92%
Ins Owner Change0%
Market Cap20.83M
Analysts82.86
Price Target5.1 (283.46%)
Short Float %6.09%
Short Ratio0.47
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.17
P/FCF N/A
P/OCF N/A
P/B 4.38
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-4.13
EYN/A
EPS(NY)-0.37
Fwd EYN/A
FCF(TTM)-0.2
FCFYN/A
OCF(TTM)-0.2
OCFYN/A
SpS0.42
BVpS0.3
TBVpS-0.75
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -219.52%
ROE -1154.56%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.26
Health
Industry RankSector Rank
Debt/Equity 1.96
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.37
Quick Ratio 0.37
Altman-Z -3.47
F-Score5
WACC10.55%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-623.42%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-18114.44%
EPS Next Y-1100%
EPS Next 2Y-182.84%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-100%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year64.83%
Revenue Next 2Y46.4%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y12.86%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year93.37%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-143.19%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-139.33%
OCF growth 3YN/A
OCF growth 5YN/A